Glen Harbor Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $165K | Buy |
2,744
+224
| +9% | +$13.5K | ﹤0.01% | 1071 |
|
|
2019
Q2 | $213K | Hold |
2,520
| – | – | ﹤0.01% | 999 |
|
|
2019
Q1 | $241K | Hold |
2,520
| – | – | 0.01% | 931 |
|
|
2018
Q4 | $178K | Hold |
2,520
| – | – | ﹤0.01% | 976 |
|
|
2018
Q3 | $215K | Buy |
2,520
+784
| +45% | +$66.9K | ﹤0.01% | 1020 |
|
|
2018
Q2 | $201K | Hold |
1,736
| – | – | ﹤0.01% | 972 |
|
|
2018
Q1 | $140K | Buy |
+1,736
| New | +$140K | ﹤0.01% | 1077 |
|
|
2017
Q1 | – | Sell |
-560
| Closed | -$19K | – | 1277 |
|
|
2016
Q4 | $19K | Buy |
+560
| New | +$19K | ﹤0.01% | 1204 |
|